A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2
Study sponsor: Invivyd, Inc. · IVVD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-11-19Actual
Enrollment · participants790Actual
Source updated2024-12-09Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.